XWELL, Inc. (XWEL) Stock

XWELL, Inc., formerly known as XpresSpa Group, Inc., operates as a prominent player in the health and wellness services sector, specializing in providing spa and medical diagnostic services primarily at airports. The company operates under several brands including XpresSpa, XpresTest, Treat, and HyperPointe, offering a range of spa services such as massage therapy, nail care, and skincare treatments. Additionally, XWELL provides an array of spa and travel-related products through its retail outlets.

In response to the global health landscape, XWELL has diversified its offerings to include wellness centers that offer critical COVID-19 screening and testing services, as well as rapid testing for other communicable diseases like influenza, RSV, Flu A&B, and seasonal flu vaccinations. These wellness centers are strategically located at airports, catering to the needs of travelers and ensuring accessible healthcare solutions.

Utilizing an integrated digital platform, XWELL enhances its service delivery by facilitating convenient booking options and seamless customer experiences. The company's approach combines physical spa locations with digital capabilities to provide a holistic wellness solution tailored to the traveling public.

Headquartered in New York, New York, XWELL continues to expand its footprint globally, operating 52 spa and clinic locations across 24 airports in the United States, the Netherlands, and the United Arab Emirates as of December 31, 2021. With a commitment to innovation and customer-centric services, XWELL aims to redefine the airport wellness experience and meet the evolving health and wellness needs of its clientele.